Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
Br J Cancer. 2007 Aug 28; 97(5): 646–653.
Published online 2007 Aug 7. doi:  10.1038/sj.bjc.6603922
PMCID: PMC2360372

Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer


Conceptual models of carcinogenesis typically consist of an evolutionary sequence of heritable changes in genes controlling proliferation, apoptosis, and senescence. We propose that these steps are necessary but not sufficient to produce invasive breast cancer because intraductal tumour growth is also constrained by hypoxia and acidosis that develop as cells proliferate into the lumen and away from the underlying vessels. This requires evolution of glycolytic and acid-resistant phenotypes that, we hypothesise, is critical for emergence of invasive cancer. Mathematical models demonstrate severe hypoxia and acidosis in regions of intraductal tumours more than 100 μm from the basement membrane. Subsequent evolution of glycolytic and acid-resistant phenotypes leads to invasive proliferation. Multicellular spheroids recapitulating ductal carcinoma in situ (DCIS) microenvironmental conditions demonstrate upregulated glucose transporter 1 (GLUT1) as adaptation to hypoxia followed by growth into normoxic regions in qualitative agreement with model predictions. Clinical specimens of DCIS exhibit periluminal distribution of GLUT-1 and Na+/H+ exchanger (NHE) indicating transcriptional activation by hypoxia and clusters of the same phenotype in the peripheral, presumably normoxic regions similar to the pattern predicted by the models and observed in spheroids. Upregulated GLUT-1 and NHE-1 were observed in microinvasive foci and adjacent intraductal cells. Adaptation to hypoxia and acidosis may represent key events in transition from in situ to invasive cancer.

Keywords: carcinogenesis, aerobic glycolysis, GLUT-1, NHE, hypoxia, mathematical models

Carcinogenesis is a time-dependent progression of cellular populations through increasingly disordered phenotypes culminating in emergence of an invasive cancer. This is often described as ‘somatic evolution' because it requires a sequence of heritable genetic changes. Classical models of carcinogenesis, such as the Fearon–Vogelstein diagram (Fearon and Vogelstein, 1990), consist of accumulating alterations in oncogenes, protooncogenes, tumour suppressor genes, and senescence pathways that increase growth-promoting signals and decrease growth inhibitors.

We have proposed (Gatenby and Gillies, 2004) that traditional conceptual models do not completely capture the underlying Darwinian dynamics because they implicitly assume that the selective pressures are internal to the cells themselves, for example resistance to apoptosis. Hence, they rarely define the specific microenvironmental selection forces and their dynamical interactions with cellular phenotypic properties, which is a fundamental requirement of a complete model. This led to application of formal evolutionary mathematical models to carcinogenesis in an effort to define specific environmental selection forces and their interactions with a range of cellular phenotypes. Model simulations demonstrated a previously unknown era of carcinogenesis dominated by hypoxia (Gatenby and Vincent, 2003; Gatenby et al, 2005). This has led to the hypothesis that adaptation of hypoxia and acidosis are necessary steps in the later phase of the carcinogenesis sequence (Figure 1).

Figure 1
(A) (from Gatenby and Gillies (2004) with permission). The evolution of breast cancer over time is shown left to right. Initial heritable changes in oncogenes, tumour suppressor genes, and senescent pathways result in unconstrained proliferation into ...

The proposal is based on recognition that somatic evolution of epithelial cancers occurs entirely within a space contained by a basement membrane. This anatomic constraint results in separation of the evolving tumour cells from the underlying stroma including blood vessels so that carcinogenesis occurs in an avascular environment. This enforces diffusion-reaction kinetics that limits substrate delivery to and metabolite removal from tumour cells as proliferation carries them progressively into the lumen. As a result, tumour cell proliferation even following multiple oncogene and tumour suppressor gene mutations may be limited by regional variations in oxygen, glucose, and H+. In the proposed carcinogenesis model, cellular adaptations to these environmental selection forces drive additional somatic evolution that is necessary for formation of an invasive cancer. Specifically, regional hypoxia promotes upregulation of glycolysis to maintain ATP production despite hypoxia, and acidosis promotes upregulation of Na+/H+ exchangers (NHEs) or mutations in apoptotic pathways to reduce acid-mediated toxicity (Park et al, 1999; Williams et al, 1999).

We propose that the final outcome of this evolutionary sequence is a population with constitutive upregulation of glycolysis and the ability to survive and proliferate in acidic conditions that would ordinarily induce quiescence or death. This constitutes a significant adaptive advantage because the phenotype creates an acidic environment (through upregulation of glycolysis) that is toxic to its competitors but less so to itself. We propose that this adaptive advantage promotes clonal expansion and invasive behaviour and that these adaptations are necessary for evolution of invasive epithelial cancers. The legacy of these evolutionary events is aerobic glycolysis (Warburg, 1930; Cherk et al, 2006) manifested by increased glucose uptake observed in FdG PET (F18-Fluorodeoxy-d-glucose positron emission tomography) scans in the overwhelming majority of primary and metastatic human cancers (Czernin and Phelps, 2002; Gambhir, 2002).

This conceptual model is supported by experimental observations of upregulation of cellular responses to hypoxia in regions of DCIS most distant from the basement membrane. This includes upregulation of hypoxia-inducible factor (HIF) and related proteins such as carbonic anhydrase IX and GLUT-1 (Wykoff et al, 2001; Brown et al, 2002). Furthermore, in vivo studies with FdG PET have demonstrated the transition from DCIS to invasive breast cancer and colonic polyps to invasive colon cancers are invariably associated with a marked increase in tumour glucose uptake (Yasuda et al, 2001; Abbey et al, 2005).

Explicit testing of the hypothesis in breast cancer through continuous observation of premalignant lesions in vivo is not feasible. Therefore, we initially examined our hypothesis using mathematical models to reproduce the nonlinear intra- and extracellular dynamics. Modelling simulations were then compared to cellular evolution in hypoxia and acidic regions of large (5–10 mm in diameter) multicellular spheroids maintained in culture for 30 days. The diffusion reaction kinetics of spheroids mimics those of intraductal tumour. To detect evolution of constitutive upregulation of glycolysis, we stained specimens for GLUT-1 since prior studies have demonstrated a direct correlation between GLUT-1 expression and increased glucose flux as measured by FdG PET (Brown et al, 1996, 2002). The presence of regional acidosis was defined by increased expression of NHE-1, which is primarily responsible for extrusion of H+ ions in MCF-7 and other breast cancer-derived populations (Bischof et al, 1996; Turturro et al, 2004). Finally, we examined clinical specimens of DCIS and invasive cancer to detect evidence for cellular response to hypoxia and acidosis similar to those predicted in the mathematical models and observed in the spheroids.


Mathematical modelling

A hybrid cellular automaton model (Patel et al, 2001; Anderson, 2005; Smallbone et al, 2005) is used to simulate carcinogenesis on a mucosal surface in which the mutant cells are separated from the blood supply by an intact basement membrane. This two-dimensional model is composed of an array of automaton elements with a specific rule-set governing their evolution, as well as oxygen, glucose, and H+ fields, each satisfying reaction-diffusion equations. Each automaton element corresponds to a normal cell, tumour cell, or a vacant space. Although normal and tumour epithelial cell diameter is variable, we assume each automaton element, and hence each tumour cell has constant diameter of 25 μm. A detailed description of the mathematical methods has been published (Smallbone et al, 2006). The mathematically inclined reader is referred to that publication and the Supplementary Appendix for a full accounting of these results.

Briefly, the model reproduces the geometry of epithelial surfaces by assuming that the bottom edge of the array represents the basement membrane. Beyond the membrane we assume the stroma is sufficiently well-vascularised such that oxygen and glucose concentrations as well as pHe remain fixed at their normal extracellular values.

Initially, the automaton consists of a layer of a normal epithelial tissue and is vacant elsewhere. We assume it to be normal epithelium growing in a monolayer along the basement membrane. Cellular metabolism in the normal epithelial layer is aerobic since the cell layer possesses a normal oxygen concentration. Similarly local pHe is physiologic (i.e. 7.4). Cells will undergo proliferation and death in response to microenvironmental and intracellular conditions. If oxygen and glucose concentrations are too low, then the cellular production of ATP drops below maintenance requirements and the cell undergoes apoptosis. Similarly, cells undergo apoptosis in response to an acidic pHe or randomly due to senescence or loss of contact with the basement membrane. Conversely, cells that have sufficient ATP (and an adjacent site is unoccupied) may proliferate to fill that site.

To initiate carcinogenesis, we assume that the cells may begin to randomly undergo three possible heritable changes through mutations or epigenetic changes. Possible cellular phenotypic properties include:


These cells proliferate under normal tissue controls so that, for example, they undergo death from senescence and apoptosis when no longer in contact with the basement membrane. Thus, cellular proliferation is limited to replacement of sites that are vacant due to cell death. This phenotype typically uses aerobic metabolism of glucose but may use anaerobic glucose metabolism so that ATP production continues (although at a lesser rate) under hypoxic conditions. The population has limited tolerance for acidic pHe and is assumed to undergo apoptosis at pHe of less than 6.8.


This phenotype is released from normal tissue growth constraints. This is meant to mimic mutations in oncogenes, senescent pathways, and tumour suppressor genes in conventional carcinogenesis models. It allows proliferation even when not in contact with the basement membrane (i.e. anoikis-resistance) and increased crowding (i.e. resistance to contact inhibition). For purposes of analysis, we assume that these changes do not alter metabolism or the toxic effects of hypoxia or acidosis; we acknowledge, however, that mutations in some genes (such as c-myc) will have dual effects on both proliferation and cellular metabolism.


These cells have constitutive upregulation of glycolysis with consequent increase in glucose uptake and acid production under all conditions including normoxia.


These cells proliferate under local pHe conditions that would produce apoptosis in normal cells. Mechanisms for increased tolerance may include mutations in apoptotic pathways (such as caspase or p53) or upregulation of NHE-1.

These mutations give rise to eight non-normal phenotype combinations, and thus eight competing cellular populations and multiple potential evolutionary pathways.

Tumour spheroids

We tested the predictions of the model using large tumour spheroids that recapitulate the diffusion reaction dynamics of substrate delivery and metabolite excretion. By maintaining the spheroids in microgravity (Doolin et al, 1999; Clejan et al, 2001; Dabos et al, 2001), we find they reliably achieve diameters of 5–10 mm. This size has three advantages: (1) it is similar to the diameter of many clinical lobular and ductal carcinoma in situ tumours; (2) it is much greater than the predicted diffusion limit of oxygen so that central regions of hypoxia and acidosis will develop; (3) it contains a larger number of cells than conventional spheroids, increasing the probability that evolution driven by rare mutations will be manifested during the 30-day observation period.

To observe specific evolutionary patterns predicted by the mathematical models, we studied MCF-7 cell line because it possesses two of the three heritable attributes used in the mathematical models: (1) it is hyperproliferative (e.g. it exhibits anchorage independent growth (Zugmaier et al, 1991)) and (2) it is resistant to acid-induced toxicity such that it remains proliferative in culture conditions even at pH of 6.5 (Figure 2). Under normal culture conditions, however, the MCF-7 cells do not exhibit constitutively upregulated glycolysis (Figure 2). Because of these phenotypic properties, we anticipate that under hypoxic and acidic conditions, MCF-7 cells will evolve phenotypes with constitutive upregulation of glycolysis, and that growth of these populations will exhibit a distinctive pattern predicted by model simulations (Figure 2, lower row) with focal nodules of glycolytic cells growing in the normoxic region of the spheroid. Finally, MUC-1 stains of MCF-7 spheroids demonstrated a basement membrane-like structure around the outer edge, further recapitulating ductal anatomy.

Figure 2
Simulations from the mathematical model described in the text showing potential evolutionary pathways in carcinoma in situ. Simulations start with a single layer of normal epithelial cells (grey cells) on a basement membrane (A). All simulations found ...

The spheroids were formed as follows: Confluent cell monolayers were incubated with 0.25% (w/v) trypsin (Sigma, UK) and 0.02% (w/v) EDTA (Sigma, UK) for 4 min at 37°C. Complete media were added to this mixture to inhibit enzyme activity. The cell suspension was passed through a 24-gauge needle, six times to ensure a single cell population. A 10 ml High Aspect Ratio Vessel (HARV; Synthecon, Houston, TX, USA) was seeded at 2 × 106 cells ml−1 in a Rotary Cell Culture System (RCCS, Austin, TX, USA) rotated at 15 r.p.m. at 37°C in a humidified atmosphere of 5% CO2 in air. The rotation speed allowed the formed aggregates to remain stationary relative to the observer. The media in the HARVs was replenished 50 : 50 every other day. A constant concentration gradient was obtained by continuous stirring of the media.

Spheroids were removed 1, 15, and 30 days after initiation. Each spheroid was fixed and stained for GLUT-1 and NHE-1.


Immunohistochemical staining for glucose transporter GLUT-1 was performed using rabbit polyclonal antibody against the C-terminal portion (Abcam, inc., Cambridge, MA, USA). The NHE-1 antibody is a rabbit polyclonal antibody (Santa Cruz Biotechnology, inc., Santa Cruz, CA, USA).

The formalin fixed, paraffin embedded spheroids were sectioned at 3 μm and baked for one hour at 60°C. Immunohistochemistry was performed using the Discovery XT Automated Staining platform (Ventana Medical Systems, Inc, Tucson, AR, USA). Deparaffinisation and antigen retrieval of tissue sections was performed online. Antigen retrieval was performed on the Ventana instrument with a borate buffer (pH 8) 40 min at 95°C. Once the tissue is conditioned in this way, several blocking steps occur on the instrument. Primary antibody is applied by hand at a 1 : 800 dilution. (60 min incubation at 37°C). Primary antibodies were visualised using VMSI validated detection and counterstaining reagents. Images were captured using an Olympus BX50 camera with an RT SPOT (Diagnostic Instruments, Inc., Sterling Heights, MI, USA). Images were standardised for light intensity. Staining was performed with primary antibody in the spheroids and clinical specimens as negative controls. In GLUT-1 staining of clinical specimens, red blood cells were used as positive controls.

Clinical specimens

Pathological specimens from 20 breast biopsies containing DCIS were subjected to immunohistochemical stains with IRB approval. Of these, five also contained regions of microscopic or gross invasive cancer. Eight of the specimens were also stained for NHE-1. In this study, we were interested in finding evidence for phenotypic adaptation to hypoxia and acidosis rather than the mechanism (i.e. activation of HIF, myc, akt, or some other pathway). For this reason, immunohistochemical analysis for overexpression of those pathways was not included in the protocols.



The model simulation demonstrates that, dependent on oxygen consumption and cells size, significant hypoxia and acidosis will occur in DCIS within about 100 μm of the basement membrane (Figure 1). This is somewhat less than the 160 μm predicted by Thomlinson and Gray (1955) or shown by Helmlinger et al (1997) and may have been a consequence of the dimensionality. While the current simulations assumed a line source of oxygen, the above measurements were performed in vivo and thus oxygen could come from multiple sources.

Since 100 μm represent only about five cell layers, it is clear that hypoxia will typically occur in any large (i.e. several mm in diameter) tumour-filled breast duct or lobule. This is consistent with prior studies showing increased carbonic anhydrase IX expression (indicating hypoxia and acidosis) is typically observed in central regions of DCIS (Wykoff et al, 2001). An unexpected finding of the simulation was the steep increase in H+ concentrations within the hypoxic regions. This is in distinction to the glucose concentrations that decrease only slightly. Thus, the simulations indicate that growth inhibition and ultimately necrosis in the central regions of DCIS is the result of both hypoxia and acidosis, and that reduced glucose concentration probably does not play a role. This requires a change in our original hypothesis (Gatenby and Gillies, 2004) which assumed central necrosis in DCIS was caused by limited glucose diffusion.

The simulations demonstrate that anaerobic metabolism compensates for decreased efficiency in ATP production with increased glucose flux. This adaptation, in turn, requires increased expression of membrane glucose transporters. Interestingly, we find that, even in the presence of oxygen, the anaerobic phenotype produces ATP at a slightly greater rate than aerobic metabolism. This slight advantage, however, is negated under aerobic conditions by the increased acid production that results in toxicity and, therefore, decreases cellular fitness. Under hypoxic conditions, the advantage of anaerobic metabolism greatly increases because it can maintain normal ATP production while it decreases considerably in the normal (aerobic) phenotype. Interestingly this suggests that acid-induced toxicity may serve as an important mechanism by which multicellular tissue enforces aerobic metabolism on individual cells.

Figure 2 shows temporal evolutionary patterns observed in model simulations. Initially, normal epithelial cells (grey) line the basement membrane. In the first stage of carcinogenesis, only those mutations that resulted in a relaxation of normal cell–cell growth constraints (pink) allowed growth. Mutations that changed glucose metabolism or acid tolerance conferred no proliferative advantage so that neither phenotypic trait was maintained in the intraductal populations.

The simulations demonstrate that alteration in growth regulators are necessary but not sufficient to form a cancer because proliferation eventually ceases as clonal expansion moves cells further into the lumen. This results in cessation of growth by hypoxia and acidosis.

During multiple simulations, cellular adaptation to these environmental selection forces followed two evolutionary pathways. In one (Figure 3, middle row), the glycolytic phenotype occurs first and becomes dominant (green). This population because of its increased expression of glucose transporters and increased glycolytic capacity produces substantially more ATP in hypoxic conditions and, so, has a competitive advantage. As demonstrated in Figure 3, the glycolytic cells replace the hyperplastic population in the hypoxic tumour regions. Note, however, that the total number of cells within the system has decreased because the increased glycolysis has resulted in higher levels of acidity, in turn inducing cell death. Further adaptation occurs to an acid-resistant phenotype (Figure 3, middle right). This population expands rapidly replacing the normal, hyperplastic, and hyperplastic plus glycolytic populations and invades into the normoxic region. This is because the population continues to use glycolytic pathways and produce local acidosis even in the presence of oxygen causing all cells with normal acid tolerance to die off.

Figure 3
(A) Cultured MCF-7 cells exhibit a low level of glucose metabolism under normoxic conditions. Under hypoxic condition, MCF-7 cells increase expression of HIF-1α resulting in upregulation of glycolysis and increased glucose consumption. This indicates ...

The second evolutionary pathway begins with emergence of the acid-resistant phenotype (blue cells in Figure 2 lower row). This allows proliferation in the acidic regions (which are also hypoxic), thus, confers a proliferative advantage permitting population expansion. A subsequent mutation that increases glycolysis generates more ATP allowing this population to expand initially in the hypoxic region. However, this phenotype appears to have only a modest adaptive advantage compared to the glycolytic, proliferative phenotype. This produces slow population growth in a distinctive nodular pattern as demonstrated in Figure 3 (lower right panel).


All three spheroids harvested at day 1 exhibited evidence of hypoxia in the core with upregulation of GLUT-1 in cells about 100–50 μm from the edge representing an adaptation to hypoxia (Figure 4). Staining for NHE-1 was observed throughout all of the cells of the spheroid at all time points so that there was no evidence of regional or temporal variations in NHE-1 (Figure 4). In two (of three) spheroids harvested at day 15 following initiation and two (of three) spheroids harvested at day 30, cells exhibiting increased GLUT-1 were observed in the periphery of the spheroid (Figure 4) which is normoxic base on both the simulations and the absence of increased GLUT 1 expression on the spheroids at day 1. In each spheroid, the nodules varied in size – a pattern remarkably similar to the model simulations. GLUT-1 and HIF-1α were co-expressed (not shown) indicating that increased glycolysis was regulated by stabilisation of HIF-1α.

Figure 4
Multiple immunohistochemistry images from spheroid at 1, 15, and 30 days following formation. The arrows mark the outer (oxygenated) edge of the spheroid. (A) Demonstrates GLUT-1 antibody distribution at day 1 with upregulation confined to the central ...

Clinical specimens

Twenty clinical specimens with DCIS were reviewed for evidence of cellular adaptations predicted by the mathematical model and observed in spheroids. In all but one of the samples, tumour cells with upregulated GLUT-1 were observed in at least some regions of DCIS. In all 19 samples, increased GLUT-1 expression was present in the central regions of intraductal tumours (Figure 5). In 17 of 19 specimens cells with upregulated GLUT-1 were also observed in the peripheral (presumably normoxic regions) of some of the intraductal tumours. In all of these cases, the cells formed clusters similar in pattern to the model simulations and spheroids suggesting that adaptation to acidosis typically precedes constitutive upregulation of glycolysis. This differs from the modelling results in which upregulated glycolysis preceded development of acid resistance in most simulation. The reason for this will be the subject of further study.

Figure 5
Examples of GLUT-1 distribution in DCIS and invasive breast cancer. (A) Shows central distribution of upregulated GLUT-1 with a gradient of intensity that parallels the transition from normoxia to hypoxia as predicted in Figure 1B and similar to the gradient ...

In four specimens, a focus of microinvasive tumour was observed adjacent to a tumour-filled duct. In each of these cases, the cells in the invasive tumour demonstrated upregulated GLUT-1 as did the cells in the periphery of the DCIS immediately adjacent to the focus of microinvasion. Upregulation of GLUT-1 was observed in cells within four of five invasive cancers (Figure 5). The cellular expression of GLUT-1 was often both membranous and cytoplasmic – a pattern previously observed (Brown et al, 2002).

Regions of cells with increased expression of NHE-1 were observed in all eight specimens examined (Figure 6). In DCIS, the distribution typically showed areas of increased expression both centrally and in the periphery. Distinctive nodules such as those seen in GLUT-1 distribution were not observed. In the four cases of microinvasion, upregulated NHE1 expression was observed both in the invasive cells and in the DCIS cells immediately adjacent to the foci of microinvasion. In all three cases of invasive cancer examined, NHE-1 was upregulated diffusely in the tumour cells.

Figure 6
(A) Shows NHE-1 distribution in DCIS. In much of the lesion, NHE-1 expression is greatest in the central hypoxic region. Some cells with strongly increased NHE-1 expression, however, are extending into the normoxic region where there is a focal bulge ...


We propose regional variations in substrate and metabolite concentrations in DCIS initiate cellular adaptations necessary for emergence of invasive breast cancer (Gatenby and Gillies, 2004). The hypothesis is framed mathematically using a modified cellular automata approach. The reaction–diffusion simulations support a key element of the hypothesis by demonstrating severe hypoxia within about five cell layers of the basement membrane in DCIS. However, the results do not support the original hypothesis that a decrease in glucose concentrations leads to central necrosis. Rather, we find that glucose concentrations decline only mildly with distance from the basement membrane while acid concentrations increase more than originally expected. The results indicate necrosis observed within DCIS is likely due to hypoxia and acidosis rather than to insufficient glucose supply.

Model simulations demonstrate that different evolutionary trajectories may occur in adaptation to hypoxia and acidosis but will generally converge to a final phenotype with constitutive upregulation of glycolysis and resistance to acid-induced toxicity. This phenotype invades into the normoxic regions of the premalignant lesion because it creates an acidic environment through upregulated glycolysis that is toxic to other cellular populations, which remain vulnerable to acid-mediated toxicity (Park et al, 1999; Williams et al, 1999; Gatenby and Gillies, 2004).

We propose this evolutionary sequence is critical in late carcinogenesis because it confers a proliferative advantage on the population and enhances invasiveness (Rohzin et al, 1994; Cuvier et al, 1997). The latter is necessary for breeching the basement membrane and transition to invasive cancer.

The model simulations predict a distinctive pattern of nodular growth when populations with constitutively increased glycolysis emerge following mutations in a dominant population that is acid resistant.

We examined this prediction by observing the evolutionary dynamics of MCF-7 cells growing in spheroids under microgravity conditions. The spheroids, which measure 5–10 mm in diameter, mimic the diffusion reaction kinetics in DCIS. At baseline, the MCF-7 cells are resistant to acid-induced toxicity but do not exhibit constitutive upregulation of glycolysis. We demonstrate evolutionary dynamics in which upregulation of GLUT-1 is initially observed only as an adaptation to hypoxia. Over time, populations of GLUT-1-positive cells are observed invading into the peripheral normoxic regions of the spheroids. The proliferation of clones of cells with upregulated GLUT-1 under physiologic conditions is consistent with our hypothesis that this phenotype confers a proliferative advantage. The nodular growth pattern is remarkably similar to the modelling predictions also supporting this hypothesis. Demonstration of a proliferative advantage to the glycolytic phenotype even under normoxic conditions provides a mechanism by which aerobic glycolysis (the Warburg effect) could arise during somatic evolution of cancer populations.

Immunohistochemical staining in DCIS demonstrated increased expression of GLUT-1 in central, hypoxic regions – a pattern also observed by Brown et al (2002). In addition, in 17 of 20 cases, we also observed some populations with upregulated GLUT-1 in the peripheral, normoxic regions of DCIS. Regions of increased NHE-1 expression were also observed in all of the DCIS specimens examined. The results are consistent with our hypothesis that hypoxia and acidosis occur frequently in DCIS, and that cellular adaptations confer an adaptive advantage that allows subsequent spread into regions that are normoxic with normal pHe.

All of the invasive cancers examined demonstrated cells with increased NHE-1 expression and four of five contained cells with upregulated GLUT-1. The latter value is slightly greater than the 61% of invasive cancers with increased GLUT-1 previously reported (Brown et al, 2002). These results support the hypothesis that the glycolytic, acid-resistant phenotype is important in transition from DCIS to invasive cancer. The absence of universal observation of upregulation GLUT-1 in invasive cancer may indicate that aerobic glycolysis is not always necessary for invasive phenotype. Alternatively, some breast cancer populations may maintain increased glycolysis through upregulated of GLUT-3 or use fatty acids rather than glucose as their dominant carbon source (Liu, 2006).

There are several limitations in the current study. We cannot with certainty know that the peripheral regions of the DCIS lesions are uniformly well oxygenated and, thus, it is possible that upregulation of GLUT1 and NHE-1 are adaptive (to regional hypoxia) rather than constitutive. Furthermore, the sample size is relatively small and the data descriptive and non-quantitative. Finally, we do not know if similar dynamics are seen in other premalignant lesions such as colon adenomas. However, the empirical results in combination with the mathematical modelling simulations do support the hypothesis that the hypoxia–glycolysis–acidosis cycle does occur in somatic evolution of breast cancer and that further investigation is warranted.

External data objects

Supplementary Appendix:


Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc)


  • Abbey CK, Borowsky AD, McGoldrick ET, Gregg JP, Maglione JE, Cardiff RD, Cherry SR. In vivo PET imaging of progression of transformation in a mouse model of mammary neoplasia. Proc Natl Acad Sci USA. 2005;101:11438–11443. [PMC free article] [PubMed]
  • Anderson ARA. A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion. Math Med Biol. 2005;22:163–186. [PubMed]
  • Bischof G, Cosentini E, Hamilton G, Riegler M, Zacherl J, Teleky B, Feil W, Schiessel R, Machen TE, Wenzl E. Effects of extracellular pH on intracellular pH-regulation and growth in a human colon carcinoma cell-line. Biochim Biophys Acta. 1996;1282:131–139. [PubMed]
  • Brown RS, Goodman TM, Zasadny KE, Greenson JK, Wahl RL. Expression of hexokinase II and Glut-1 in untreated human breast cancer. Nuclear Med and Biol. 2002;29:443–453. [PubMed]
  • Brown RS, Leung JY, Fisher SJ, Frey KA, Ethier SP, Wahl RL. Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake. J Nuc Med. 1996;37:1042–1047. [PubMed]
  • Cherk MH, Foo SS, Poon AM, Knight SR, Murone C, Papenfuss AT, Sachinidis JI, Saunder TH, O'Keefe GJ, Scott AM. lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-fluoromisonidazole and 18F-FDG PET. J Nucl Med. 2006;47:1921–1926. [PubMed]
  • Clejan S, O'Connor K, Rosensweig N. Tri-dimensional prostate cell cultures in simulated microgravity and induced changes in lipid second messengers and signal transduction. J Cell Mol Med. 2001;5:60–73. [PubMed]
  • Cuvier C, Jang A, Hill RP. Exposure to hypoxia, glucose starvation and acidosis: effect on invasive capacity of murine tumor cells and correlation with cathepsin (L + B) secretion. Clin Exp Metast. 1997;15:19–25. [PubMed]
  • Czernin J, Phelps ME. Positron emission tomography scanning: current and future applications. Ann Rev Med. 2002;53:89–112. [PubMed]
  • Dabos KJ, Nelson LJ, Bradnock TJ, Parkinson JA, Sadler IH, Hayes PC, Plevris JN. The simulated microgravity environment maintains key metabolic functions and promotes aggregation of primary porcine hepatocytes. Biochim Biophys Acta. 2001;1526:119–130. [PubMed]
  • Doolin EJ, Geldziler B, Strande L, Kain M, Hewitt C. Effects of microgravity on growing cultured skin constructs. Tissue Eng. 1999;5:573–581. [PubMed]
  • Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759–767. [PubMed]
  • Gambhir SS. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer. 2002;2:683–693. [PubMed]
  • Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004;4:891–899. [PubMed]
  • Gatenby RA, Vincent TL. An evolutionary model of carcinogenesis. Cancer Res. 2003;63:6212–6220. [PubMed]
  • Gatenby RA, Vincent TL, Gillies RJ. Evolutionary dynamics in carcinogenesis. Mathematical Models and Methods in Applied Sciences. 2005;15:1–20.
  • Helmlinger G, Yuan F, Dellian M, Jain RK. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med. 1997;3:177–182. [PubMed]
  • Liu Y. Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer. Prostate Cancer Prostatic Dis. 2006;9:230–234. [PubMed]
  • Park HJ, Lyons JC, Ohtsubo T, Song CW. Acidic environment causes apoptosis by increasing caspase activity. Br J Cancer. 1999;80:1892–1897. [PMC free article] [PubMed]
  • Patel AA, Gawlinski ET, Lemieux SK, Gatenby RA. A cellular automaton model of early tumor growth and invasion. J Theor Biol. 2001;213:315–331. [PubMed]
  • Rohzin J, Sameni M, Ziegler G, Sloane BF. Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res. 1994;54:6517–6525. [PubMed]
  • Smallbone K, Gatenby RA, Gillies RJ, Maini PK, Gavaghan DJ. Metabolic changes during carcinogenesis: potential impact on invasiveness. J Theor Biol. 2006;235:476–484. [PubMed]
  • Smallbone K, Gavaghan DJ, Gatenby RA, Maini PK. The role of acidity in solid tumour growth and invasion. J Theor Biol. 2005;235:476–484. [PubMed]
  • Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer. 1955;9:539–549. [PMC free article] [PubMed]
  • Turturro F, Friday E, Fowler R, Surie D, Welbourned T. Troglitazone acts on cellular pH and DNA synthesis through a peroxixome proliferator-activated recepto gamma-independent mechanism in breast cancer-derived cell lines. Clin Cancer Res. 2004;10:7022–7030. [PubMed]
  • Warburg O. The Metabolism of Tumours. London: Constable Press; 1930.
  • Williams AC, Collard TJ, Paraskeva C. An acidic environment leads to p53 dependent induction of apoptosis. Oncogene. 1999;16:3199–3204. [PubMed]
  • Wykoff CC, Beasley NJ, Watson PH, Campo L, Chia SK, English R, Pastorek J, Sly WS, Ratcliffe P, Harris AL. Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. Am J Pathol. 2001;158:1011–1019. [PMC free article] [PubMed]
  • Yasuda S, Fujii H, Nakahara T, Hishiumi N, Takahashi W, Ide M, Shohtsu A. 18F-FDG PET detection of colonic adenomas. J Nucl Med. 2001;42:989–992. [PubMed]
  • Zugmaier G, Knabbe C, Fritsch C, Simpson S, Ennis B, Lippman M, Dickson RB. Tissue culture conditions determine the effects of estrogen and growth factors on the anchorage independent growth of human breast cancer cell lines. Steroid Biochem Mol Biol. 1991;39:681–685. [PubMed]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK
PubReader format: click here to try


Save items

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Compound
    PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...